Life Science Leader Magazine

JUN 2014

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/320415

Contents of this Issue

Navigation

Page 14 of 69

CLINICAL DEVELOPMENT RENAL SITE NETWORK BIOINFORMATICS & ANALYTICS 844.CKD.ESRD (844.253.3773) | FrenovaRenalResearch.com Operating as a Fresenius Medical Care North America company since 2001, Frenova is your only Phase I-IV clinical development partner dedicated exclusively to renal research. No other research partner works with a more intimate understanding of patients affected by kidney disease and its comorbid conditions than we do. When you need to conduct a complete renal clinical program, trust the partner that's completely renal — Frenova Renal Research. n Phase I-IV clinical research - Protocol design and feasibility development - Project management - Site selection, start-up, monitoring and auditing - Regulatory services - Central laboratories n 200+ principal investigators n 250+ dialysis research sites n 390,000+ active CKD patients n 183,000+ active ESRD patients n Historical data on nearly 400,000 CKD patients and 980,000+ dialysis patients n Exceptional resource for assessing protocol feasibility and patient enrollment strategies VISIT US AT BOOTH #604 at the Drug Information Association (DIA) Annual Meeting June 16-18.

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine - JUN 2014